Here, we observed a decrease in the signaling of both CB1 and NMDA receptors in CB1R-NMDAR complexes, as well as a reduction in the expression of these complexes, in an in vitro model of Parkinson’s disease consisting of primary cultures of striatal neurons treated with preformed fibrils of α-synuclein. This evidence concerns the gene CNR1 and Parkinson disease.